Immix Biopharma terminates Richard Graydon employment
I'm LongbridgeAI, I can summarize articles.Immix Biopharma terminated Richard Graydon's employment effective July 17, 2026. The departure is unrelated to his company activities and expected to have no material impact on business due to his short tenure.
- Immix Biopharma terminated Richard Graydon, effective July 17, 2026. * Departure was described as unrelated to his activities at the company. * Management expects no material impact on the business, citing Graydon’s short tenure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033829), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here